These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors. Burke MJ; Walterhouse DO; Jacobsohn DA; Duerst RE; Kletzel M Pediatr Blood Cancer; 2007 Aug; 49(2):196-8. PubMed ID: 17417796 [TBL] [Abstract][Full Text] [Related]
25. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells. van Besien K; Margolin K; Champlin R; Forman S Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395 [TBL] [Abstract][Full Text] [Related]
26. Autologous PBSC transplant for late onset AML after mafosfamide-purged and TBI-containing autologous BMT. Bassan R; Cortelazzo S; Rambaldi A; Cornelli P; Borleri G; Bellavita P; Biondi A; Barbui T Bone Marrow Transplant; 1995 May; 15(5):791-3. PubMed ID: 7670409 [TBL] [Abstract][Full Text] [Related]
28. High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. Graham-Pole J; Lazarus HM; Herzig RH; Gross S; Coccia P; Weiner R; Strandjord S Am J Pediatr Hematol Oncol; 1984; 6(1):17-26. PubMed ID: 6370012 [TBL] [Abstract][Full Text] [Related]
29. Induction of immune resistance against L1210 lymphatic leukemia in mice after chemoradiotherapy of the leukemia and reconstitution with bone marrow purged from the leukemia with mafosfamide. Skórski T; Kawalec M Exp Hematol; 1988 Oct; 16(9):782-4. PubMed ID: 3049130 [TBL] [Abstract][Full Text] [Related]
30. [High-dosage melphalan followed by bone marrow autotransplant in solid tumors of childhood: our experience]. Sánchez de Toledo Codina J; Gallego Melcón S; Pérez Payarols J; Prats Viñas J; Javier G; Massuet L; Macià Martí J Med Clin (Barc); 1986 Apr; 86(15):621-3. PubMed ID: 3014240 [No Abstract] [Full Text] [Related]
31. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors. Vaughan WP Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558 [No Abstract] [Full Text] [Related]
32. G-CSF-primed peripheral blood progenitor cells (PBPC) support in high-risk Ewing sarcoma of childhood. Prete A; Rosito P; Alvisi P; Rondelli R; Melchionda F; Magrini E; Pession A Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S21-3. PubMed ID: 9989884 [TBL] [Abstract][Full Text] [Related]
33. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation. Lopez M; Mary JY; Sainteny F Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567 [TBL] [Abstract][Full Text] [Related]
34. High-dose melphalan +/- total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor. Stewart DA; Gyonyor E; Paterson AH; Arthur K; Temple W; Schachar NS; Klassen J; Brown C; Russell JA Bone Marrow Transplant; 1996 Aug; 18(2):315-8. PubMed ID: 8864440 [TBL] [Abstract][Full Text] [Related]
35. [Autologous bone marrow transplantation in pediatric oncology]. Wagner HP; Baumgartner C; Bleher EA; Brun del Re G; Bucher U; Deubelbeiss KA; Greiner R; Hirt A; Imbach P; Lüthy A; Odavic R Monatsschr Kinderheilkd; 1982 Nov; 130(11):814-6. PubMed ID: 6759924 [No Abstract] [Full Text] [Related]
36. Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia. Peters SO; Stockschläder M; Hegewisch-Becker S; Krüger W; Weh HJ; Hossfeld DK; Zander AR Bone Marrow Transplant; 1995 May; 15(5):783-4. PubMed ID: 7670406 [TBL] [Abstract][Full Text] [Related]
37. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Shankar AG; Ashley S; Craft AW; Pinkerton CR Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341 [TBL] [Abstract][Full Text] [Related]
38. [Prognosis and therapeutic results in hematopoietic tumors of the bone system]. Papolczy A; Molnár L Orv Hetil; 1972 Jun; 113(23):1344-7. PubMed ID: 4555311 [No Abstract] [Full Text] [Related]
39. Defective cytokine production following autologous stem cell transplantation for solid tumors and hematologic malignancies regardless of bone marrow or peripheral origin and lack of evidence for a role for interleukin-10 in delayed immune reconstitution. Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Leblanc P; Symann ML Cancer Res; 1994 Jul; 54(14):3800-7. PubMed ID: 7913409 [TBL] [Abstract][Full Text] [Related]
40. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow. Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]